Showing results (181-190 of 407) with videos related to

Sort By:
Pageof 41
Plos One|February 14, 2008
Prevention of hypovolemic circulatory collapse by IL-6 activated Stat3Jeffrey A Alten, Ana Moran, Anna I Tsimelzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survivalR L Rocha, S G Hilsenbeck, J G Jackson, et al.
Scandinavian Journal of Gastroenterology|April 25, 2009
Gene expression in Barrett's esophagus: laser capture versus whole tissueHashem B El-Serag, Zhannat Z Nurgalieva, Toni-Ann Mistretta, et al.
Cornea|September 1, 1995
Standardization of conjunctival impression cytologyA J Martinez, M B Mills, K B Jaceldo, et al.
Neoplasia (New York, N.Y.)|September 9, 2010
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesisMichael J Toneff, Zhijun Du, Jie Dong, et al.
The American Journal of Pathology|October 1, 1995
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancerJ J Isola, O P Kallioniemi, L W Chu, et al.
Blood|February 5, 2017
CSF-1-induced Src signaling can instruct monocytic lineage choiceMax Endele, Dirk Loeffler, Konstantinos D Kokkaliaris, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Effects of recombinant human interleukin-1 alpha on clonogenic growth of primary human tumors in vitroA R Hanauske, D Degen, M H Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomyS G Diab, S G Hilsenbeck, C de Moor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival ratesTorsten A Hopp, Heidi L Weiss, Susan G Hilsenbeck, et al.
Pageof 41